Literature DB >> 19884578

Sudomotor dysfunction in autoimmune autonomic ganglionopathy.

K Kimpinski1, V Iodice, P Sandroni, R D Fealey, S Vernino, P A Low.   

Abstract

BACKGROUND: Autoimmune autonomic ganglionopathy is characterized by impairment of multiple autonomic domains of which sudomotor function is among the most common. Many patients with this disorder have difficulties with thermoregulation and anhidrosis. Our objective was to characterize the distribution and severity of sudomotor dysfunction in this disorder.
METHODS: Sudomotor function was analyzed in a cohort of 21 patients with ganglionic alpha3 nicotinic acetylcholine receptor (nAChR) antibody positive autoimmune autonomic ganglionopathy. Standard measurements of sudomotor function were used including the Thermoregulatory Sweat Test and Quantitative Sudomotor Axon Reflex Test.
RESULTS: The clinical presentation in all patients was characterized by widespread sudomotor dysfunction. Sudomotor impairment was predominantly postganglionic in 17 of the 21 patients studied. Higher ganglionic alpha3 nAChR antibody levels resulted in progressive postganglionic predominant dysfunction (postganglionic, r = 0.637, p = 0.002; mixed ganglionic, r = 0.709, p < 0.001). The pattern of anhidrosis on Thermoregulatory Sweat Testing was consistent with a ganglionopathy in the majority of patients (14 of 21) and a distal pattern in a minority of patients (8 of 21). These patterns of anhidrosis coupled with increasing postganglionic dysfunction in a proximal to distal pattern (foot > distal leg > proximal leg > forearm) indicate lesions at both the ganglia and distal axon of the postganglionic sudomotor sympathetic neuron.
CONCLUSIONS: Our data characterize the unique sudomotor dysfunction in autoimmune autonomic ganglionopathy as widespread, predominantly postganglionic, and a result of lesions at both the ganglia and distal axon. This study provides important support to the hypothesis that this disorder represents a ganglionic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884578      PMCID: PMC2779006          DOI: 10.1212/WNL.0b013e3181bf995f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Evaluation of sudomotor function.

Authors:  Phillip A Low
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Neuronal ganglionic acetylcholine receptor autoimmunity.

Authors:  Steven Vernino; Vanda A Lennon
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

4.  Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody.

Authors:  Paola Sandroni; Steven Vernino; Caroline M Klein; Vanda A Lennon; Lisa Benrud-Larson; David Sletten; Phillip A Low
Journal:  Arch Neurol       Date:  2004-01

5.  Experimental autoimmune autonomic neuropathy.

Authors:  Steven Vernino; Phillip A Low; Vanda A Lennon
Journal:  J Neurophysiol       Date:  2003-05-28       Impact factor: 2.714

6.  The spectrum of autoimmune autonomic neuropathies.

Authors:  Caroline M Klein; Steven Vernino; Vanda A Lennon; Paola Sandroni; Robert D Fealey; Lisa Benrud-Larson; David Sletten; Phillip A Low
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

7.  Mechanisms of acetylcholine receptor loss in myasthenia gravis.

Authors:  D B Drachman; R N Adams; E F Stanley; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

8.  Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.

Authors:  V Iodice; K Kimpinski; S Vernino; P Sandroni; R D Fealey; P A Low
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

9.  Passive transfer of autoimmune autonomic neuropathy to mice.

Authors:  Steven Vernino; Leonid G Ermilov; Lei Sha; Joseph H Szurszewski; Phillip A Low; Vanda A Lennon
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

10.  Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.

Authors:  Vanda A Lennon; Leonid G Ermilov; Joseph H Szurszewski; Steven Vernino
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more
  6 in total

1.  Sudomotor dysfunction in autoimmune autonomic ganglionopathy: a follow-up study.

Authors:  Kurt Kimpinski; Valeria Iodice; Paola Sandroni; Robert D Fealey; Steven Vernino; Phillip A Low
Journal:  Clin Auton Res       Date:  2011-11-30       Impact factor: 4.435

2.  Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure.

Authors:  Jeremy K Cutsforth-Gregory; Andrew McKeon; Elizabeth A Coon; David M Sletten; Mariana Suarez; Paola Sandroni; Wolfgang Singer; Eduardo E Benarroch; Robert D Fealey; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2018-08-28       Impact factor: 7.616

Review 3.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

4.  Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients.

Authors:  Shunya Nakane; Osamu Higuchi; Michiaki Koga; Takashi Kanda; Kenya Murata; Takashi Suzuki; Hiroko Kurono; Masanari Kunimoto; Ken-ichi Kaida; Akihiro Mukaino; Waka Sakai; Yasuhiro Maeda; Hidenori Matsuo
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  Accessing autonomic function can early screen metabolic syndrome.

Authors:  Kan Sun; Yu Liu; Meng Dai; Mian Li; Zhi Yang; Min Xu; Yu Xu; Jieli Lu; Yuhong Chen; Jianmin Liu; Guang Ning; Yufang Bi
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

6.  Study on autonomic dysfunction and metabolic syndrome in Chinese patients.

Authors:  Ling Zhu; Xiaolan Zhao; Ping Zeng; Jianguo Zhu; Shuwen Yang; Annan Liu; Yuehua Song
Journal:  J Diabetes Investig       Date:  2016-05-09       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.